Aarti Pharmalabs Ltd. (APL) has announced the inauguration of a state of the art chemistry R&D center at Nerul, Navi Mumbai.

The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects, which will ensure better science and complex chemistry solutions to innovator pharma and biotech clients.

Being a global small molecule drug substance CDMO, the company will continue its investments in world class facilities, latest technologies, and skilled talent to offer innovative development and manufacturing solutions to its clients.

The company supports pharma and life sciences fraternity that continue to benefit patients across the globe.

Aarti Pharmalabs Limited is an established, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, NCE, and xanthine derivatives situated in India. In order to build a sustainable future, the company integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).